# Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant

> **NCT02668315** · PHASE1,PHASE2 · COMPLETED · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 25 (actual)

## Conditions studied

- Hematologic Malignancy

## Interventions

- **BIOLOGICAL:** Transplantation of cord blood expanded with UM171

## Key facts

- **NCT ID:** NCT02668315
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-16
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-08-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02668315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02668315, "Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02668315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*